Our Thesis
European healthcare founders build world-class innovations, yet often lack a clear pathway into new frontier markets, such as India, the world's fastest-growing healthcare market.
Market entry requires infrastructure and deep local expertise that no founder can build alone. We provide that infrastructure, backed by real on-ground capability and trusted local networks.
We exist to bridge this gap, turning global innovation into scalable opportunity.
About Metl
The ability to cope well with difficulties; strength of character.
The fund takes its name from a deliberate creative compression. "Metl" is a stylised rendering of mettle — the quality of resilience, resolve, and willingness to take on hard things.
Entering a new market demands more than capital. It demands conviction in the face of the unfamiliar, the patience to build without a map, and the resolve to hold a position when the path is unclear. Metl captures precisely what this fund's mandate requires — from the GPs who structured it, to the founders carrying European innovation into one of the world's most complex and rewarding markets.
The fund thesis is predicated on conviction that European MedTech and HealthTech ventures have a genuine place in the Indian market, a thesis that requires mettle to back.
The companies Metl backs are not passive recipients of capital. They are European ventures making the deliberate, demanding choice to internationalise into a market with its own regulatory logic, distribution architecture, and commercial culture.
Founders who say yes to India say yes to complexity. Metl is the partner that understands it, respects it, and has the experience to help them navigate and unlock markets to drive valuation uplift.
Our Team
We're a Europe–India GP team, with boots on the ground in both geographies.
We're not just a fund. We're a team that has built the infrastructure, navigated the markets, managed capital at scale, and delivered the exits.
Get in Touch
Metl is currently in early fundraising. If you are an investor, family office or a founder, who believes in opening new frontier markets for European MedTech & HealthTech ventures, we would love to hear from you.
